Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, 100039, Beijing, China.
Department of clinical laboratory, The Fifth Medical Center of Chinese PLA General Hospital, 100039, Beijing, China.
Dig Liver Dis. 2023 Nov;55(11):1554-1561. doi: 10.1016/j.dld.2023.08.045. Epub 2023 Sep 29.
The microbial spectrum and antimicrobial resistance patterns change over time and vary across regions in patients with spontaneous bacterial peritonitis (SBP). There is an urgent need to clarify the factors associated with in-hospital mortality in these patients.
In this study, 377 patients with SBP and 794 patients with bacterascites were analyzed for the microbial spectrum, antimicrobial resistance profiles, and laboratory findings.
The most common pathogens were Escherichia coli (96, 25.5%), Staphylococcus epidermidis (55, 14.6%), and Enterococcus faecium (42, 11.1%). Multidrug-resistant (MDR) bacteria comprised 49.7% of gram-positive bacteria (GPB) and 48.8% of gram-negative bacteria (GNB). The most sensitive antibiotics were amikacin (91.5%), meropenem (89.8%) and piperacillin/tazobactam (87.6%). Extensively drug-resistant (XDR) (OR=51.457, p < 0.001), neutrophil count (OR=1.088, p < 0.001), and the model for end-stage liver disease (MELD) score (OR=1.124, p < 0.001) were independent predictive factors of in-hospital mortality in patients with SBP.
MDR represented nearly half of the bacteria isolated from patients with SBP, of which the high prevalence of extended-spectrum β-lactamase-producing and Carbapenem-resistant bacteria is concerning. The presence of XDR, higher MELD score, and neutrophil count were independent predictive factors associated with higher in-hospital mortality in patients with SBP, indicating that intensive care should be provided to these patients.
自发性细菌性腹膜炎(SBP)患者的微生物谱和抗菌药物耐药模式随时间推移而变化,且在不同地区存在差异。因此,迫切需要明确这些患者住院死亡率相关的因素。
本研究分析了 377 例 SBP 患者和 794 例细菌性腹水患者的微生物谱、抗菌药物耐药谱和实验室检查结果。
最常见的病原体是大肠埃希菌(96 例,25.5%)、表皮葡萄球菌(55 例,14.6%)和屎肠球菌(42 例,11.1%)。革兰阳性菌(GPB)中耐药菌(MDR)占 49.7%,革兰阴性菌(GNB)中耐药菌占 48.8%。最敏感的抗生素是阿米卡星(91.5%)、美罗培南(89.8%)和哌拉西林/他唑巴坦(87.6%)。广泛耐药(XDR)(OR=51.457,p<0.001)、中性粒细胞计数(OR=1.088,p<0.001)和终末期肝病模型(MELD)评分(OR=1.124,p<0.001)是 SBP 患者住院死亡率的独立预测因素。
MDR 菌几乎占 SBP 患者分离菌的一半,其中产超广谱β-内酰胺酶和耐碳青霉烯类的细菌比例较高令人担忧。XDR、较高的 MELD 评分和中性粒细胞计数是与 SBP 患者住院死亡率较高相关的独立预测因素,提示应对这些患者进行强化治疗。